Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IDIX > SEC Filings for IDIX > Form 8-K on 6-Jun-2014All Recent SEC Filings

Show all filings for IDENIX PHARMACEUTICALS INC

Form 8-K for IDENIX PHARMACEUTICALS INC


6-Jun-2014

Submission of Matters to a Vote of Security Holders


Item 5.07 Submission of Matters to a Vote of Security Holders

Idenix Pharmaceuticals, Inc. (the "Company") held its annual meeting of stockholders on June 5, 2014. At the annual meeting, the stockholders elected all of the nominees of the Company's Board of Directors for a term of one year and until his or her successor is duly elected and qualified. In addition, at the annual meeting, the stockholders (i) approved the Company's 2014 Employee Stock Purchase Plan and the reservation of 2,000,000 shares for future issuance thereof, (ii) ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year ending December 31, 2014, and (iii) approved on an advisory basis the compensation of the Company's named executive officers as disclosed in the proxy statement for the 2014 Annual Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the Summary Compensation Table and the other related tables and narrative disclosure.

The final voting results are set forth below:

a) The following nominees for director were elected as follows:

      Nominee                             For           Withheld        Non-Votes
      Wayne T. Hockmeyer, Ph.D.        120,564,194       2,139,355       13,040,775
      Thomas R. Hodgson                120,594,787       2,108,762       13,040,775
      Tamar D. Howson                  120,355,081       2,348,468       13,040,775
      Denise Pollard-Knight, Ph.D.     120,564,094       2,139,455       13,040,775
      Ronald C. Renaud, Jr.            122,631,265          72,284       13,040,775
      Charles Rowland, Jr.             120,602,491       2,101,058       13,040,775
      Michael Wyzga                    120,605,177       2,098,372       13,040,775

b) The Company's 2014 Employee Stock Purchase Plan and the reservation of 2,000,000 shares for future issuance thereof was approved as follows:

                            For:           122,447,648
                            Against:           214,819
                            Abstain:            41,082
                            Non Votes:      13,040,775

c) The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm the current fiscal year ending December 31, 2014 was approved as follows:

                             For:         135,532,642
                             Against:         122,421
                             Abstain:          89,261



d) The compensation of the Company's named executive officers was approved on an advisory basis as disclosed in the proxy statement for the 2014 Annual Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the Summary Compensation Table and the other related tables and narrative disclosure. The final voting results were as follows:

                            For:           120,430,366
                            Against:         2,233,538
                            Abstain:            39,645
                            Non Votes:      13,040,775


  Add IDIX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IDIX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.